The use of standardized Brazilian green propolis extract (EPP-AF) as an adjunct treatment for hospitalized COVID-19 patients (BeeCovid2): a structured summary of a study protocol for a randomized controlled trial

BACKGROUND: The 2019 coronavirus disease (COVID-19) pandemic continues to spread and affects large numbers of people with unprecedented impacts. Experimental evidence has already been obtained for use of the standardized extract of Brazilian green propolis (EPP-AF) against viral targets, and clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Silveira, Marcelo Augusto Duarte, de Souza, Sergio Pinto, dos Santos Galvão, Erica Batista, Teixeira, Maurício Brito, Gomes, Marcel Miranda Dantas, Damiani, Lucas Petri, Bahiense, Bruno Andrade, Cabral, Julia Barros, De Oliveira, Cicero Wandson Luiz Macedo, Mascarenhas, Talita Rocha, Pinheiro, Priscila Carvalho Guedes, Alves, Milena Souza, de Melo, Rodrigo Morel Vieira, Berretta, Andresa Aparecida, Leite, Flávia Mendes, Nonaka, Carolina Kymie Vasques, de Freitas Souza, Bruno Solano, Mendes, Ana Verena Almeida, da Guarda, Suzete Farias, da Hora Passos, Rogério
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978159/
https://www.ncbi.nlm.nih.gov/pubmed/35379306
http://dx.doi.org/10.1186/s13063-022-06176-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978159/
https://www.ncbi.nlm.nih.gov/pubmed/35379306
http://dx.doi.org/10.1186/s13063-022-06176-1

Ejemplares similares